Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Ishii-Watabe

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2020
[Role of the Japanese Pharmacopoeia in the Quality Assurance of Biologics]Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 2022
[What Is an Antibody Test? Characteristics of Antibodies against SARS-CoV-2 and Their Tests]Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 4, 2018
[Site-specific O-Glycosylation Analysis of Therapeutic Fc-fusion Protein by Mass Spectrometry]Noritaka Hashii, Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Characterization of Therapeutic Monoclonal Antibodies by Using FcγR-expressing Reporter Cell LinesMinoru Tada, Akiko Ishii-Watabe
Drug Metabolism and Pharmacokinetics|January 3, 2019
Biosimilarity assessment of biosimilar therapeutic monoclonal antibodiesAkiko Ishii-Watabe, Takashi Kuwabara
Biochemical and Biophysical Research Communications|April 10, 2022
FcγRIIIa-158V/F polymorphism affects the performance of FcγRIIIa-related bioassayMichihiko Aoyama, Minoru Tada, Akiko Ishii-Watabe
Mabs|January 9, 2018
Development and characterization of an anti-rituximab monoclonal antibody panelMinoru Tada, Takuo Suzuki, Akiko Ishii-Watabe
Journal of Pharmaceutical Sciences|November 3, 2019
Fcγ Receptor Activation by Human Monoclonal Antibody AggregatesMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2022
[Quality Evaluation of Therapeutic Antibodies by Multi-attribute Method]Noritaka Hashii, Michiko Tajiri, Akiko Ishii-Watabe
Mabs|June 13, 2023
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complexMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2020
[Role of the Japanese Pharmacopoeia in the Quality Assurance of Biologics]Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 2022
[What Is an Antibody Test? Characteristics of Antibodies against SARS-CoV-2 and Their Tests]Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 4, 2018
[Site-specific O-Glycosylation Analysis of Therapeutic Fc-fusion Protein by Mass Spectrometry]Noritaka Hashii, Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2017
Characterization of Therapeutic Monoclonal Antibodies by Using FcγR-expressing Reporter Cell LinesMinoru Tada, Akiko Ishii-Watabe
Drug Metabolism and Pharmacokinetics|January 3, 2019
Biosimilarity assessment of biosimilar therapeutic monoclonal antibodiesAkiko Ishii-Watabe, Takashi Kuwabara
Biochemical and Biophysical Research Communications|April 10, 2022
FcγRIIIa-158V/F polymorphism affects the performance of FcγRIIIa-related bioassayMichihiko Aoyama, Minoru Tada, Akiko Ishii-Watabe
Mabs|January 9, 2018
Development and characterization of an anti-rituximab monoclonal antibody panelMinoru Tada, Takuo Suzuki, Akiko Ishii-Watabe
Journal of Pharmaceutical Sciences|November 3, 2019
Fcγ Receptor Activation by Human Monoclonal Antibody AggregatesMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2022
[Quality Evaluation of Therapeutic Antibodies by Multi-attribute Method]Noritaka Hashii, Michiko Tajiri, Akiko Ishii-Watabe
Mabs|June 13, 2023
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complexMinoru Tada, Michihiko Aoyama, Akiko Ishii-Watabe
Pageof 14